SCHEMBL4865243

SCHEMBL4865243

CCCCCCCCCCCCCOCC(C)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.67
USP2 O75604 1/20 0.64
HTT P42858 2/20 0.62
SPHK1 Q9NYA1 1/20 0.61
LPAR5 Q9H1C0 4/20 0.53
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
THRB P10828 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PRKD3 O94806 1/20 0.50
PRKCG P05129 1/20 0.50
PRKCB P05771 1/20 0.50
PRKCA P17252 1/20 0.50
PRKCH P24723 1/20 0.50
PRKCI P41743 1/20 0.50
PRKCE Q02156 1/20 0.50
PRKCQ Q04759 1/20 0.50
PRKCZ Q05513 1/20 0.50
PRKCD Q05655 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661581 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7549303 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL9637036 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL7775489 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL187451 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL15070143 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL1091934 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL10745894 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL186489 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5
SCHEMBL21046009 1.00 HSD17B10 (0.67) HSD17B10USP2HTTSPHK1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190169218-A1 AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2019-06-06 US disclosed
EP-1541643-B1 Nonionic associative thickener containing condensation polymer backbone ROHM & HAAS (US) 2013-03-13 EP disclosed
US-7432325-B2 Nonionic associative thickener containing condensation polymer backbone ROHM AND HAAS COMPANY (US) 2008-10-07 US disclosed
US-20060106153-A1 Nonionic associative thickener containing condensation polymer backbone ROHM AND HAAS COMPANY 2006-05-18 US disclosed
EP-1541643-A1 Nonionic associative thickener containing condensation polymer backbone ROHM AND HAAS COMPANY (US) 2005-06-15 EP disclosed
US-4704218-A FRICTION REDUCING, ANTIWEAR MOBIL OIL CORPORATION 1987-11-03 US disclosed
US-4000315-A Cyclopropane esters for the control of mites ZOECON CORPORATION (US) 1976-12-28 US disclosed
US-3957849-A MITICIDES ZOECON CORPORATION (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169218-A1 AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF UGCG, APMAP, GID4 HSD17B10 1180/4885USP2 3446/4885HTT 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.